Raras
Buscar doenças, sintomas, genes...
Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata
Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

A malformação de Dandy–Walker (MDW), também conhecida como síndrome de Dandy–Walker (SDW), é uma rara malformação cerebral congênita em que a parte que une os dois hemisférios do cerebelo não se forma completamente, e o quarto ventrículo e o espaço atrás do cerebelo ficam aumentados com líquido cefalorraquidiano. A maioria dos indivíduos afetados desenvolve hidrocefalia no primeiro ano de vida, que pode se manifestar como aumento do tamanho da cabeça, vômitos, sonolência excessiva, irritabilidade, desvio dos olhos para baixo e convulsões.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Casos conhecidos
2
pacientes catalogados
Início
Infancy
+ neonatal
🏥
SUS: Cobertura completaScore: 90%
PCDT disponível3 medicamentos CEAFTriagem neonatal (Fase 5)Centros em: PA, PE, BA, CE, PB +10CID-10: G12.8
🇧🇷Dados SUS / DATASUS
PROCEDIMENTOS SIGTAP (2)
0202010694
Sequenciamento completo do exoma (WES)genetic_test
0301070040
Atendimento em reabilitação — doenças rarasrehabilitation
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👁️
Olhos
1 sintomas
🧠
Neurológico
1 sintomas
🦴
Ossos e articulações
1 sintomas
💪
Músculos
1 sintomas

+ 3 sintomas em outras categorias

Características mais comuns

90%prev.
Catarata
Muito frequente (99-80%)
90%prev.
Malformação de Dandy-Walker
Muito frequente (99-80%)
90%prev.
Hipoplasia do vermis cerebelar
Muito frequente (99-80%)
90%prev.
Amiotrofia distal do membro inferior
Muito frequente (99-80%)
90%prev.
Cisterna magna aumentada
Muito frequente (99-80%)
90%prev.
Fraqueza muscular distal
Muito frequente (99-80%)
7sintomas
Muito frequente (7)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 7 características clínicas mais associadas, ordenadas por frequência.

CatarataCataract
Muito frequente (99-80%)90%
Malformação de Dandy-WalkerDandy-Walker malformation
Muito frequente (99-80%)90%
Hipoplasia do vermis cerebelarCerebellar vermis hypoplasia
Muito frequente (99-80%)90%
Amiotrofia distal do membro inferiorDistal lower limb amyotrophy
Muito frequente (99-80%)90%
Cisterna magna aumentadaEnlarged cisterna magna
Muito frequente (99-80%)90%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos200publicações
Pico202477 papers
Linha do tempo
2026Hoje · 2026📈 2024Ano de pico
Publicações por ano (últimos 10 anos)

Triagem neonatal (Teste do Pezinho)

👶
Teste: qPCR para deleção de SMN1 em sangue seco
Fase 5 do PNTNpending
Incidência no Brasil: 1:10.000

A triagem neonatal permite diagnóstico precoce e início imediato do tratamento.

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

🧬

Nenhum gene associado encontrado

Os dados genéticos desta condição ainda estão sendo catalogados.

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata

Centros de Referência SUS

24 centros habilitados pelo SUS para Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata

Centros para Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata

Detalhes dos centros

Hospital Universitário Prof. Edgard Santos (HUPES)

R. Dr. Augusto Viana, s/n - Canela, Salvador - BA, 40110-060 · CNES 0003808

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Infantil Albert Sabin

R. Tertuliano Sales, 544 - Vila União, Fortaleza - CE, 60410-794 · CNES 2407876

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital de Apoio de Brasília (HAB)

AENW 3 Lote A Setor Noroeste - Plano Piloto, Brasília - DF, 70684-831 · CNES 0010456

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Estadual Infantil e Maternidade Alzir Bernardino Alves (HIABA)

Av. Min. Salgado Filho, 918 - Soteco, Vila Velha - ES, 29106-010 · CNES 6631207

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital das Clínicas da UFG

Rua 235 QD. 68 Lote Área, Nº 285, s/nº - Setor Leste Universitário, Goiânia - GO, 74605-050 · CNES 2338424

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital Universitário da UFJF

R. Catulo Breviglieri, Bairro - s/n - Santa Catarina, Juiz de Fora - MG, 36036-110 · CNES 2297442

Atenção Especializada

Rota
Anomalias Congênitas

Hospital das Clínicas da UFMG

Av. Prof. Alfredo Balena, 110 - Santa Efigênia, Belo Horizonte - MG, 30130-100 · CNES 2280167

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Julio Müller (HUJM)

R. Luis Philippe Pereira Leite, s/n - Alvorada, Cuiabá - MT, 78048-902 · CNES 2726092

Atenção Especializada

Rota
Anomalias Congênitas

Hospital Universitário João de Barros Barreto

R. dos Mundurucus, 4487 - Guamá, Belém - PA, 66073-000 · CNES 2337878

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Lauro Wanderley (HULW)

R. Tabeliao Estanislau Eloy, 585 - Castelo Branco, João Pessoa - PB, 58050-585 · CNES 0002470

Atenção Especializada

Rota
Anomalias Congênitas

Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)

R. dos Coelhos, 300 - Boa Vista, Recife - PE, 50070-902 · CNES 0000647

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Pequeno Príncipe

R. Des. Motta, 1070 - Água Verde, Curitiba - PR, 80250-060 · CNES 3143805

Serviço de Referência

Rota
Anomalias CongênitasDeficiência Intelectual

Hospital Universitário Regional de Maringá (HUM)

Av. Mandacaru, 1590 - Parque das Laranjeiras, Maringá - PR, 87083-240 · CNES 2216108

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UFPR

R. Gen. Carneiro, 181 - Alto da Glória, Curitiba - PR, 80060-900 · CNES 2364980

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário Pedro Ernesto (HUPE-UERJ)

Blvd. 28 de Setembro, 77 - Vila Isabel, Rio de Janeiro - RJ, 20551-030 · CNES 2280221

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira (IFF/Fiocruz)

Av. Rui Barbosa, 716 - Flamengo, Rio de Janeiro - RJ, 22250-020 · CNES 2269988

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital São Lucas da PUCRS

Av. Ipiranga, 6690 - Jardim Botânico, Porto Alegre - RS, 90610-000 · CNES 2232928

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital de Clínicas de Porto Alegre (HCPA)

Rua Ramiro Barcelos, 2350 Bloco A - Av. Protásio Alves, 211 - Bloco B e C - Santa Cecília, Porto Alegre - RS, 90035-903 · CNES 2237601

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital Universitário da UFSC (HU-UFSC)

R. Profa. Maria Flora Pausewang - Trindade, Florianópolis - SC, 88036-800 · CNES 2560356

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo

Hospital das Clínicas da FMUSP

R. Dr. Ovídio Pires de Campos, 225 - Cerqueira César, São Paulo - SP, 05403-010 · CNES 2077485

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Base de São José do Rio Preto

Av. Brg. Faria Lima, 5544 - Vila Sao Jose, São José do Rio Preto - SP, 15090-000 · CNES 2079798

Atenção Especializada

Rota
Anomalias Congênitas

Hospital de Clínicas da UNICAMP

R. Vital Brasil, 251 - Cidade Universitária, Campinas - SP, 13083-888 · CNES 2748223

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

Hospital de Clínicas de Ribeirão Preto (HCRP-USP)

R. Ten. Catão Roxo, 3900 - Vila Monte Alegre, Ribeirão Preto - SP, 14015-010 · CNES 2082187

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do MetabolismoDeficiência Intelectual

UNIFESP / Hospital São Paulo

R. Napoleão de Barros, 715 - Vila Clementino, São Paulo - SP, 04024-002 · CNES 2688689

Serviço de Referência

Rota
Anomalias CongênitasErros Inatos do Metabolismo
Sobre os centros SUS: Estes centros são habilitados pelo Ministério da Saúde como Serviços de Referência em Doenças Raras ou Serviços de Atenção Especializada. O atendimento é pelo SUS, com encaminhamento da rede de atenção básica.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Local Translation in Glial Cells of the Brain.

Annual review of cell and developmental biology2026 Mar 16

Local protein synthesis is a conserved mechanism that allows cells with intricate architectures to perform compartment-specific functions. By translating messenger RNAs (mRNAs) at distinct subcellular locations, cells can respond swiftly and precisely to localized stimuli. This strategy is crucial in neurons, whose long processes extend far from the cell body. Disruptions in neuronal local translation have been implicated in neurological disorders, including fragile X syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. While much of the spotlight has been on neurons, glial cells-microglia, astrocytes, oligodendrocytes, and radial glia-are increasingly recognized for their own dynamic use of local translation. These support cells exhibit asymmetric mRNA localization, suggesting that local protein synthesis plays key roles in their diverse functions. This review explores the emerging landscape of local translation in glial cells and examines how this finely tuned process contributes to both normal brain function and the development of neurological disease.

#2

A Translational Roadmap for Neurological Nonsense Mutation Disorders.

International journal of molecular sciences2026 Jan 30

Nonsense mutations, responsible for ~11% of gene lesions causing human monogenic diseases, introduce premature termination codons (PTCs) that lead to truncated proteins and nonsense-mediated mRNA decay (NMD). In the central nervous system (CNS), these mutations drive severe, progressive neurological conditions such as spinal muscular atrophy, Rett syndrome, and Duchenne muscular dystrophy. Readthrough therapies-strategies to override PTCs and restore full-length protein expression-have evolved from early aminoglycosides to modern precision tools including suppressor tRNAs, RNA editing, and CRISPR-based platforms. Yet clinical translation remains hampered by inefficient CNS delivery, variable efficacy, and the absence of personalized stratification. In this review, we propose a translational framework-the 4 Ds of Readthrough Therapy-to systematically address these barriers. The framework dissects the pipeline into Detection (precision patient identification and biomarker profiling), Delivery (engineered vectors for CNS targeting), Decoding (context-aware molecular correction), and Durability (long-term safety and efficacy). By integrating advances in machine learning, nanocarriers, base editing, and adaptive trial designs, this roadmap provides a structured strategy to bridge the translational gap. We advocate that a synergistic, modality-tailored approach will transform nonsense suppression from palliative care to durable, precision-based cures for once-untreatable neurological disorders.

#3

AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model.

Journal of biomedical science2026 Jan 04

Mutations in the Immunoglobulin Mu DNA Binding Protein 2 (IGHMBP2) gene cause Spinal Muscular Atrophy with Respiratory Distress type 1 (SMARD1), a rare, infantile, and fatal motor neuron disease, as well as the milder Charcot-Marie-Tooth disease type 2S (CMT2S). Gene therapy has emerged as a promising approach to correcting IGHMBP2 loss in SMARD1 models, but critical challenges remain. In this study, we compared the efficacy of two novel, optimized adeno-associated virus 9 (AAV9)-IGHMBP2 vectors, utilizing either the Chicken β-Actin (CBA) or a truncated form of the methyl-CpG-binding protein 2 (MeCP2) promoter (P546), in the SMARD1 murine model via intracerebroventricular delivery. Treated mice survival, histopathological and molecular profile were analyzed. Corroborating previous findings, both constructs effectively rescued the pathological phenotype, significantly improving survival, body weight, and motor function while preserving motor neurons and neuromuscular junctions. Notably, histopathological and RNA sequencing analyses revealed, for the first time, inflammatory marker alterations in the SMARD1 spinal cord, which resolved following treatment. A comparative analysis of the two vectors demonstrated superior long-term efficacy of the P546-promoter construct. ICV gene therapy approach can effectively rescue SMARD1 pathological hallmarks, including astrogliosis and microgliosis. Moreover, P546-promoter construct is superior in terms of safety profile and long-term therapeutic efficacy.

#4

Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.

Gene therapy2026 Jan
#5

Clinical-genetic features of the TBCE-related spectrum disorders: A focus on the childhood-onset neurodegenerative phenotype.

Molecular genetics and metabolism2026 Mar 04

Tubulin-folding cofactor E (TBCE) plays a central role in tubulin heterodimer formation and disaggregation. Both TBCE biallelic and monoallelic pathogenic variants have been associated with human diseases involving endocrine and/or neurologic system. This study aimed to expand current knowledge on the neurodegenerative phenotype associated with TBCE variants, and to explore possible genotype-phenotype correlations. Subjects with a neurodegenerative syndrome caused by biallelic TBCE variants were recruited from three centers. Clinical, genetic, neuroimaging and neurophysiological data were collected retrospectively and, when available, longitudinally. A systematic literature review focusing on genotype-phenotype correlations was also performed. Thirteen subjects, including eight newly reported and five previously published, were enrolled. Data from 322 additional patients were available from systematic literature review, for a total of 335 TBCE mono- and biallelic patients. Sanjad-Sakati syndrome was the most frequent form (85%), while the neurodegenerative phenotype accounted for a minority (5%) of cases. TBCE-related neurodegeneration ranged from progressive spastic-ataxic tetraparesis, optic atrophy and distal motor axonal neuropathy, consistent with already named PEAMO (progressive encephalopathy with amyotrophy and optic atrophy) to milder complex spastic paraparesis. Brain imaging often revealed progressive thinning of the corpus callosum, cerebro-cerebellar atrophy, white matter abnormalities and possible iron accumulation in deep grey matter structures. Additional relevant features included scoliosis, respiratory and gastrointestinal dysfunctions. Genotype-phenotype correlation and a distinct geographic distribution were identified across phenotypes. Pathogenic biallelic TBCE variants present phenotypic heterogeneity, with at least four different phenotypes, with genotype-phenotype correlation. TBCE-related neurodegeneration is a severe multisystem disorder that requires multidisciplinary management.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 196

2026

Local Translation in Glial Cells of the Brain.

Annual review of cell and developmental biology
2026

Clinical-genetic features of the TBCE-related spectrum disorders: A focus on the childhood-onset neurodegenerative phenotype.

Molecular genetics and metabolism
2026

To Do Or Not To Do: Therapeutic Hypothermia Treatment For An Infant With HIE And Prenatal Spinal Muscular Atrophy With Congenital Bone Fractures.

Journal of mother and child
2026

MLDP-AS: an optimized next-generation sequencing assay for enhanced detection of technically challenging variants in expanded carrier screening.

Journal of translational medicine
2026

A Translational Roadmap for Neurological Nonsense Mutation Disorders.

International journal of molecular sciences
2026

Early onset scoliosis in syndromic and neuromuscular disorders: A multidisciplinary approach.

Journal of clinical orthopaedics and trauma
2026

[Chinese expert consensus on the diagnosis and treatment of Becker muscular dystrophy].

Zhonghua nei ke za zhi
2026

Sleep in children with spinal muscular atrophy and their caregivers: Exploring sleep problems and the need for care.

Research in developmental disabilities
2026

Pain Hypersensitivity in a Mouse Model of Marfan Syndrome.

Antioxidants (Basel, Switzerland)
2026

AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model.

Journal of biomedical science
2026

Phenotypic continuum in IGHMBP2-related disorders: a portfolio of cases from typical to Guillain-Barré syndrome-like presentation.

Neuromuscular disorders : NMD
2025

Human Mutant Dynactin Subunit 1 Causes Profound Motor Neuron Disease Consistent with Possible Mechanisms Involving Axonopathy, Mitochondriopathy, Protein Nitration, and T-Cell-Mediated Cytolysis.

Biomolecules
2025

Newborn screening for SCID and severe T- and B-cell lymphopenia in Ukraine: the first analysis of the results, 2022-2025.

Frontiers in immunology
2025

Effective Radiotherapy for Bilateral Hip Flexion Dysfunction Due to Vertebral Metastasis at the Origin of the Psoas Major: A Case Report.

Cureus
2025

Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai.

Human genomics
2025

Resilience and physical functioning trajectories in people aging with disability: concordance and determinants over seven years.

Innovation in aging
2025

Sleep quality, restless legs syndrome and daytime sleepiness in adults with 5q-spinal muscular atrophy.

Journal of neuromuscular diseases
2025

U.S. health plan coverage of Neuromuscular Disease Therapies: An assessment of policy availability and restrictions.

Journal of neuromuscular diseases
2026

Real-world evidence supporting orphan drugs approvals for rare neuromuscular disorders in the European Union and the United States: Review of public assessment reports (2015-2025).

Current opinion in pharmacology
2025

Diagnostic Value of Exome Sequencing in Isolated Polyhydramnios.

Prenatal diagnosis
2025

SMN deficiency inhibits endochondral ossification via promoting TRAF6-induced ubiquitination degradation of YBX1 in spinal muscular atrophy.

Bone research
2025

Antisense molecules: A promising new therapy for atopic dermatitis.

Acta pharmaceutica Sinica. B
2026

Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.

Gene therapy
2025

The Ighmbp2-R604X mouse presents with the most severe SMARD1 clinical symptoms resulting in failure to thrive, respiratory and feeding deficits, aspiration and severe axon and muscle pathology.

Neurobiology of disease
2026

Modified Camitz versus flexor digitorum superficialis of the fourth finger opponensplasty in severe carpal tunnel syndrome: A systematic review.

Hand surgery &amp; rehabilitation
2025

[Musculoskeletal disorders in patients with Parkinson's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
2026

Concurrent diagnosis of spinal muscular atrophy and trisomy 21: Value of comprehensive analysis in prenatal genetic testing.

Clinica chimica acta; international journal of clinical chemistry
2025

The Neuromuscular Junction: A Shared Vulnerability in Aging and Disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience
2025

Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union.

Neurology international
2025

Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience.

International journal of neonatal screening
2025

Administration of Onasemnogene Abeparvovec in an Infant With Spinal Muscular Atrophy and PCR-Confirmed SARS-CoV-2 Infection.

Cureus
2025

[Neuromuscular diseases in pediatrics with specific treatments].

Medicina
2026

Utilization of Induced Pluripotent Stem Cell-Derived Neurons to Investigate the Splice-Modification Efficacy of Splice-Switching Drug Candidates.

Methods in molecular biology (Clifton, N.J.)
2025

Pediatric acute respiratory distress syndrome in children with type I - spinal muscular atrophy: a 12-year case series.

European journal of pediatrics
2025

Who declines, who maintains? Trajectories of physical function and the role of social determinants of health in adults aging with physical disability.

The journals of gerontology. Series B, Psychological sciences and social sciences
2025

Open-label phase IV trial evaluating nusinersen after onasemnogene abeparvovec in children with spinal muscular atrophy.

The Journal of clinical investigation
2025

TFIIH-p52ΔC defines a ninth xeroderma pigmentosum complementation-group XP-J and restores TFIIH stability to p8-defective trichothiodystrophy.

The Journal of clinical investigation
2025

Antenatal Ultrasound Findings in Spinal Muscular Atrophy Type 0.

Molecular genetics &amp; genomic medicine
2025

Co-occurrence of ipsilateral partial Horner's syndrome in a patient with monomelic amyotrophy.

BMJ case reports
2025

Reproductive carrier screening for genetic disorders: position statement of the Canadian College of Medical Geneticists.

Journal of medical genetics
2025

Visual hallucinations due to oral baclofen withdrawal.

Medicina clinica
2025

Application of the Gross Motor Function Measure in children with conditions other than cerebral palsy: A systematic review.

Developmental medicine and child neurology
2025

DCTN1-associated neurological disorder with symptoms similar to spinal bulbar muscular atrophy.

Journal of neuromuscular diseases
2025

A Novel Approach to Trunk Rehabilitation: Designing an Upper Body Robotic Mobilizer for Neurological Disorders.

IEEE ... International Conference on Rehabilitation Robotics : [proceedings]
2025

Vertebral Bone Density Abnormalities in Fetal Ultrasound: A Distinctive Clinical Sign of Spondylocarpotarsal Synostosis Syndrome MYH3-Related.

Australasian journal of ultrasound in medicine
2025

Couple-Based Carrier Screening: How Gene and Variant Considerations Impact Outcomes.

Genes
2025

Mortality Associated With Viral Bronchiolitis in a Pediatric Department: A Retrospective Analysis.

Cureus
2025

Genome Sequencing Uncovers Additional Findings in Phelan-McDermid Syndrome.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
2025

Pharmaceutical perspectives on oligonucleotide therapeutics and delivery systems.

Pharmacological reviews
2025

Cervical Muscle Composition in Degenerative Dropped Head Syndrome: A Propensity Score Matching Study.

Spine
2025

Costs of Treating Onasemnogene Abeparvovec-Xioi-Induced Liver Injury.

Pharmacology research &amp; perspectives
2025

Supine Bridge Exercise for Low Back Pain: A Fascial Approach for Movement Impairment Syndromes (Part II).

Cureus
2025

Gene therapy of rare diseases as a milestone in medicine - overview of the field and report on initial experiences in Slovenia.

Orphanet journal of rare diseases
2025

One-way self-expanding rods for early onset neuromuscular scoliosis: a two-year follow-up of an international cohort.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2025

Osilodrostat Safety Profile: Findings from Real-World Data in the FAERS Database.

Journal of clinical medicine
2025

Pontocerebellar Hypoplasia Type 1 and Associated Neuronopathies.

Genes
2025

Gene replacement therapy to restore polyamine metabolism in a Snyder-Robinson syndrome mouse model.

Methods in enzymology
2025

Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.

Journal of clinical medicine
2025

Clinical and Genetic Landscape of IGHMBP2 -Related Disorders: From Novel Variants to Phenotypic Insights.

American journal of medical genetics. Part A
2025

Postmarketing adverse events associated with onasemnogene abeparvovec: a real-world pharmacovigilance study.

Orphanet journal of rare diseases
2025

Guidelines for reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy.

Pathology
2026

Anatomic Localization and Compression Points of Occipital Nerves: Therapeutic Insights Using K-Means and Cadaveric Atlas.

Operative neurosurgery (Hagerstown, Md.)
2025

Cost-effectiveness of population-based expanded reproductive carrier screening for genetic diseases in Australia: a microsimulation analysis.

European journal of human genetics : EJHG
2025

Nationwide Survey of Oral Function Management in Patients With Neuromuscular Intractable Diseases in Japan.

Cureus
2025

Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study.

Orphanet journal of rare diseases
2025

Sensory Dysfunction in ALS and Other Motor Neuron Diseases: Clinical Relevance, Histopathology, Neurophysiology, and Insights from Neuroimaging.

Biomedicines
2025

Targeted long-read sequencing facilitates effective carrier screening for complex monogenic diseases including spinal muscular atrophy, α-/β-thalassemia, 21-hydroxylase deficiency, and fragile-X syndrome.

Journal of translational medicine
2025

Prevalence and incidence rates of 17 neuromuscular disorders: An updated review of the literature.

Journal of neuromuscular diseases
2025

The POLG Variant c.678G>C; p.(Gln226His) Is Associated with Mitochondrial Abnormalities in Fibroblasts Derived from a Patient Compared to a First-Degree Relative.

Genes
2025

[Genetic defects in Braunvieh cattle of Switzerland - an overview].

Schweizer Archiv fur Tierheilkunde
2025

Wearable sensors in paediatric neurology.

Developmental medicine and child neurology
2025

Favorable response to ketogenic diet therapy in a patient with DYNC1H1-related epilepsy.

Epilepsy &amp; behavior reports
2025

A novel UBA1 gene mutation in a patient with infantile respiratory distress syndrome.

Human genome variation
2024

Insights into diagnostic difficulties in spinal muscular atrophy: a Case Report series.

Frontiers in genetics
2025

RNA-binding proteins in disease etiology: fragile X syndrome and spinal muscular atrophy.

RNA (New York, N.Y.)
2024

Offering reproductive genetic carrier screening for cystic fibrosis, spinal muscular atrophy and fragile X syndrome: Views of Victorian general practitioners.

Australian journal of general practice
2024

Adverse events of nusinersen: a real-world drug safety surveillance study based on the FDA adverse event reporting system (FAERS) database.

Expert opinion on drug safety
2025

Genetic study on candidates for oocyte donation.

JBRA assisted reproduction
2024

Case Report: Atypical motor development in a patient with the mosaic form of Down syndrome and spinal muscular atrophy type 2- long-term observation.

Frontiers in genetics
2024

A Modular Genetic Approach to Newborn Screening from Spinal Muscular Atrophy to Sickle Cell Disease-Results from Six Years of Genetic Newborn Screening.

Genes
2025

HMGCS1 variants cause rigid spine syndrome amenable to mevalonic acid treatment in an animal model.

Brain : a journal of neurology
2024

A new ICT system coupling electromyography and coma recovery scale-revised to support the diagnostic process in disorders of consciousness.

Scientific reports
2024

Comprehensive newborn screening for severe combined immunodeficiency, X-linked agammaglobulinemia, and spinal muscular atrophy: the Chinese experience.

World journal of pediatrics : WJP
2024

Genotype‒phenotype correlation in recessive DNAJB4 myopathy.

Acta neuropathologica communications
2025

Ighmbp2 mutations and disease pathology: Defining differences that differentiate SMARD1 and CMT2S.

Experimental neurology
2024

Conceptual Framework of Upper Cross Syndrome: A Delphi Study.

Cureus
2024

A Rare Genetic Intersection: Down Syndrome With Coexisting Spinal Muscular Atrophy.

Cureus
2024

Effects of platelet-rich plasma injection on electrical activity and biomechanics of the erector spinae muscles in lumbar myofascial pain syndrome.

Scientific reports
2024

The Lateral Corticospinal Tract Sign: An MRI Marker for Amyotrophic Lateral Sclerosis.

Radiology
2025

Research Progress of Camptocormia in Parkinson Disease.

Clinical spine surgery
2024

Surgical Improvement of Neuropathy-Induced Calf Muscle Hypertrophy and Creatine Kinase Elevation: A Case Report.

Cureus
2024

Structural perspectives on the androgen receptor, the elusive shape-shifter.

Steroids
2024

Oximetry and carbon dioxide screening for ventilatory requirements in children with spinal muscular atrophy type 1-3.

Sleep medicine
2024

The Clinical Heterogeneity of Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1)-A Report of Three Cases, Including Twins.

Genes
2024

Neurosurgical gene therapy for central nervous system diseases.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2024

The Association between prior arthroplasty and Paraspinal Muscle Degeneration in patients undergoing elective lumbar surgery.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society
2024

The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data.

EClinicalMedicine
2024

Burden of rare genetic disorders in India: twenty-two years' experience of a tertiary centre.

Orphanet journal of rare diseases
2024

Clinically relevant mouse models of severe spinal muscular atrophy with respiratory distress type 1.

Human molecular genetics
2024

Camptocormia in a young man with anti-GAD-seropositive stiff-person syndrome.

BMJ case reports
2024

The molecular mechanisms that underlie IGHMBP2-related diseases.

Neuropathology and applied neurobiology
2024

Parsonage-Turner Syndrome and SARS-CoV-2 Infection: A Literature Review With Case Presentation.

Cureus
2024

Complex Regional Pain Syndrome in a Non-traumatic Case: A Case Report.

Cureus
2024

Minimally Invasive Placement of Pedicle Screws Using Robotic-Assisted Navigation and Magnetically Controlled Growing Rods in a Patient with Early-Onset Scoliosis: Technical Note and Case Report.

Journal of orthopaedic case reports
2024

Disproportionality Analysis of Nusinersen in the Food and Drug Administration Adverse Event Reporting System: A Real-World Postmarketing Pharmacovigilance Assessment.

Pediatric neurology
2024

[Carrier screening for 223 monogenic diseases in Chinese population: a multi-center study in 33 104 individuals].

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
2024

Androgen receptor post-translational modifications and their implications for pathology.

Biochemical Society transactions
2024

Periodic limb movements during sleep in children with neuromuscular disease or cerebral palsy - An important potential contributor to sleep-related morbidity.

Sleep medicine
2024

Truncated variants of MAGEL2 are involved in the etiologies of the Schaaf-Yang and Prader-Willi syndromes.

American journal of human genetics
2024

An updated systematic review on spinal muscular atrophy patients treated with nusinersen, onasemnogene abeparvovec (at least 24 months), risdiplam (at least 12 months) or combination therapies.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2024

Fluoroscopy guided teardrop technique for open trans-muscular iliac screw placement and open reduction maneuvers during modified triangular spinopelvic fixation for unstable U-shaped sacral and tile C pelvic traumas: technical note.

Neurosurgical review
2024

The Role of Rehabilitation after Spinal Mesotherapy in a Three-Stage Treatment Concept.

Journal of clinical medicine
2024

Metabolic syndrome is common in adults with 5q-spinal muscular atrophy and impacts quality of life and fatigue.

Muscle &amp; nerve
2025

Challenges of Providing Optimal and Safe Intrapartum Analgesia in Patients With HELLP Syndrome: A Case Report and Literature Review.

Military medicine
2025

STAC3 disorder: a common cause of congenital hypotonia in Southern African patients.

European journal of human genetics : EJHG
2024

Role of ERK in gender difference of fibromyalgia pain.

Molecular pain
2024

The various forms of hereditary motor neuron disorders and their historical descriptions.

Journal of neurology
2024

Prevalence of Lower Cross Syndrome in Housemaids.

Cureus
2024

Dry needling in the management of chronic tension-type headache associated with levator scapulae syndrome: A case report.

Clinical case reports
2024

Spectrum of sleep-disordered breathing and quality of sleep in adolescent and adult patients with spinal muscular atrophy.

Journal of sleep research
2024

Pre-op considerations in neuromuscular scoliosis deformity surgery: proceedings of the half day course at the 58th annual meeting of the Scoliosis Research Society.

Spine deformity
2024

A Comprehensive Study of the Potential Compression Points of the Third Occipital Nerve and Its Possible Clinical Interests.

Plastic and reconstructive surgery
2024

Clinical application value of pre-pregnancy carrier screening in Chinese Han childbearing population.

Molecular genetics &amp; genomic medicine
2024

Gross and histopathological findings in hindlimb paralysis syndrome in wild Carnaby's black cockatoos (Zanda laitirostris).

Journal of comparative pathology
2024

State of art of mobility medicine: some more abstracts and evidence that the success of Pdm3 is based on extra-session relationships.

European journal of translational myology
2024

Clinical Reasoning: A 19-Month-Old Girl With Infantile-Onset Myopathy and White Matter Changes.

Neurology
2024

HIV-associated nemaline myopathy manifesting as bent spine syndrome.

BMJ case reports
2024

Preimplantation genetic testing for monogenic disorders (PGT-M) offers an alternative strategy to prevent children from being born with hereditary neurological diseases or metabolic diseases dominated by nervous system phenotypes: a retrospective study.

Journal of assisted reproduction and genetics
2024

MECP2-related disorders while gene-based therapies are on the horizon.

Frontiers in genetics
2024

Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets.

medRxiv : the preprint server for health sciences
2024

Case report: Klinefelter syndrome may protect against the development of spinal and bulbar muscular atrophy.

Frontiers in neurology
2024

The contribution and therapeutic implications of IGHMBP2 mutations on IGHMBP2 biochemical activity and ABT1 association.

Biochimica et biophysica acta. Molecular basis of disease
2024

CRISPR-Based Gene Editing Techniques in Pediatric Neurological Disorders.

Pediatric neurology
2024

Minimally invasive resection of a prominent transverse process in neurogenic thoracic outlet syndrome: new application for a primarily spinal approach. Illustrative case.

Journal of neurosurgery. Case lessons
2024

RNA helicase IGHMBP2 regulates THO complex to ensure cellular mRNA homeostasis.

Cell reports
2024

Shared and distinct mechanisms of UBA1 inactivation across different diseases.

The EMBO journal
2024

Early prenatal diagnosis of causative homozygous variants in ASCC1 in a fetus with cystic hygroma and additional homozygous variants of unknown significance associated with a neurological phenotype not visible in early gestation: Dual diagnosis or not?

Prenatal diagnosis
2024

Efficacy and Safety of Spinal Collagen Mesotherapy in Patients with Chronic Low Back Pain in a Three-Month Follow-Up-Retrospective Study.

Journal of clinical medicine
2024

Hereditary spastic paraparesis type 46 (SPG46): new GBA2 variants in a large Italian case series and review of the literature.

Neurogenetics
2024

Pseudo-obstructive sleep disordered breathing - definition and progression in Spinal Muscular Atrophy.

Sleep medicine
2024

[Variant analysis and prenatal diagnosis for two Chinese pedigrees affected with Spinal muscular atrophy with respiratory distress type 1].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2024

Neurochemical mechanism of muscular pain: Insight from the study on delayed onset muscle soreness.

The journal of physiological sciences : JPS
2024

Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care.

Biotech (Basel (Switzerland))
2023

Agenesis of Pectoralis Major Muscle in Late-Onset GFPT1-Related Congenital Myasthenic Syndrome: A Case Report.

Neurology. Genetics
2024

A Novel Heterozygous De Novo MORC2 Missense Variant Causes an Early Onset and Severe Neurodevelopmental Disorder.

Case reports in genetics
2024

Deep intronic variant causes aberrant splicing of ATP7A in a family with a variable occipital horn syndrome phenotype.

European journal of medical genetics
2024

Fat embolism syndrome in Duchenne muscular dystrophy: Report on a novel case and systematic literature review.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society
2023

Current Status and Advancements in Platelet-Rich Plasma Therapy.

Cureus
2024

What patient parameters influence lumbar stiffness in patients with hip pathology?

Journal of orthopaedic research : official publication of the Orthopaedic Research Society
2023

Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study.

Clinical drug investigation
2024

Prenatal diagnosis of isolated bilateral clubfoot: Is amniocentesis indicated?

Acta obstetricia et gynecologica Scandinavica
2023

Congenital Torticollis in a Child With Cervical Spine Deformity: A Case Report and Literature Review.

Cureus
2024

Spinal Muscular Atrophy Type 1 Survival Without New Pharmacotherapies: Two Treatment Paradigms.

American journal of physical medicine &amp; rehabilitation
2023

Challenges in the identification of nocturnal respiratory events in adult patients affected by spinal muscular atrophy.

Sleep medicine
2023

A pilot study of an integrated, personalized, respiratory and motor telerehabilitation program for pediatric patients with hereditary neuromuscular disorders.

Muscle &amp; nerve
2023

Lethal immunotoxicity in high-dose systemic AAV therapy.

Molecular therapy : the journal of the American Society of Gene Therapy
2024

Exploring factors impacting haplotype-based noninvasive prenatal diagnosis for single-gene recessive disorders.

Clinical genetics
2024

Volume assured pressure support mode use for non-invasive ventilation in pediatrics.

Pediatric pulmonology
2024

[Growth-preserving instrumentation for early onset scoliosis].

Operative Orthopadie und Traumatologie
2023

SELENON-Related Myopathy Across the Life Span, a Cross-Sectional Study for Preparing Trial Readiness.

Journal of neuromuscular diseases
2023

Sleep disordered breathing in infants identified through newborn screening with spinal muscular atrophy.

Sleep medicine
2023

RNA-Binding Proteins: A Role in Neurotoxicity?

Neurotoxicity research
2023

Pediatric Neuromuscular Diseases.

Pediatric neurology
2023

Adenosine A2A signals and dystonia.

International review of neurobiology
2023

Management of Critically Ill Patients With Spinal Muscular Atrophy Admitted With Acute Respiratory Failure: The Authors' Reply.

Respiratory care
2023

Spinal and bulbar muscular atrophy combined with hypertrophic cardiomyopathy and Brugada-pattern electrocardiographic changes: A case report.

Echocardiography (Mount Kisco, N.Y.)
2024

Treatment of primary restless legs syndrome with Fu's subcutaneous needling: A case report.

Explore (New York, N.Y.)
2023

In inflammatory myopathies, dropped head/bent spine syndrome is associated with scleromyositis: an international case-control study.

RMD open
2023

Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.

Ontario health technology assessment series
2023

Slowly progressive late-onset spinal muscular atrophy Finkel-type related to p.Pro56Ser VABP mutation in Colombia.

Amyotrophic lateral sclerosis &amp; frontotemporal degeneration
2023

An Unusual Diagnostic Journey Through MLPA: From Spinal Muscular Atrophy to a Severe Case of Prader-Willi Syndrome.

Journal of clinical practice and research
2024

Inaugural dropped head syndrome and camptocormia in inflammatory myopathies: a retrospective study.

Rheumatology (Oxford, England)
2023

Dietary Implications of the Bidirectional Relationship between the Gut Microflora and Inflammatory Diseases with Special Emphasis on Irritable Bowel Disease: Current and Future Perspective.

Nutrients
2023

Neurofilament Light Chain: A Translational Safety Biomarker for Drug-Induced Peripheral Neurotoxicity.

Toxicologic pathology
2023

The identification of protein and RNA interactors of the splicing factor Caper in the adult Drosophila nervous system.

Frontiers in molecular neuroscience
2023

A TRPV4 mutation caused Charcot-Marie-Tooth disease type 2C with scapuloperoneal muscular atrophy overlap syndrome and scapuloperoneal spinal muscular atrophy in one family: a case report and literature review.

BMC neurology
2023

Effect of the COVID-19 pandemic on outpatient care and rehabilitation in neuromuscular clinical practice in Japan: a health insurance claims database analysis.

BMJ open
2023

Charting the Next Road Map for CSF Biomarkers in Alzheimer's Disease and Related Dementias.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
2023

SMN regulates GEMIN5 expression and acts as a modifier of GEMIN5-mediated neurodegeneration.

Acta neuropathologica
2023

Methods and results of neurosurgical treatment of cerebral palsy.

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko
2023

The First Registered Type 0 Spinal Muscular Atrophy Patient in Latvia: Call for Change in Prenatal Diagnostic Procedures.

Case reports in medicine
2023

Dropped Head Syndrome As a Presenting Sign of Different Diseases: Report of Three Cases.

Noro psikiyatri arsivi
2023

Spinal Muscular Atrophy with Progressive Myoclonic Epilepsy (SMA-PME): three new cases and review of the mutational spectrum.

Italian journal of pediatrics
2023

VRK1 variants at the cross road of Cajal body neuropathogenic mechanisms in distal neuropathies and motor neuron diseases.

Neurobiology of disease
2023

Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen.

Journal of neuromuscular diseases
2023

Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency.

Communications biology
2023

In a zebrafish biomedical model of human Allan-Herndon-Dudley syndrome impaired MTH signaling leads to decreased neural cell diversity.

Frontiers in endocrinology
2023

[A prospective study of genetic screening of 2 060 neonates by high-throughput sequencing].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2023

Gene Therapy for Dopamine Dyshomeostasis: From Parkinson's to Primary Neurotransmitter Diseases.

Movement disorders : official journal of the Movement Disorder Society
2023

Post-polio syndrome presenting as isolated neck extensor myopathy: a case report.

AME case reports
2023

Axial Postural Abnormalities in Parkinsonism: Gaps in Predictors, Pathophysiology, and Management.

Movement disorders : official journal of the Movement Disorder Society
2023

[Clinical and genetic characteristics of 9 rare cases with coexistence of dual genetic diagnoses].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2023

Non-Functional Jaw Muscular Activity in Patients with Disorders of Consciousness Revealed by A Long-Lasting Polygraphy.

Diagnostics (Basel, Switzerland)
2023

Chemistry, structure and function of approved oligonucleotide therapeutics.

Nucleic acids research
2023

Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases.

IBRO neuroscience reports
2023

Sporadic Spinal-Onset Amyotrophic Lateral Sclerosis Associated with Myopathy in Three Unrelated Portuguese Patients.

Brain sciences

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Local Translation in Glial Cells of the Brain.
    Annual review of cell and developmental biology· 2026· PMID 41838432mais citado
  2. A Translational Roadmap for Neurological Nonsense Mutation Disorders.
    International journal of molecular sciences· 2026· PMID 41683838mais citado
  3. AAV9 gene therapy optimization for SMARD1/CMT2S: safety and long-term efficacy comparison of two vectors in a SMARD1 preclinical model.
    Journal of biomedical science· 2026· PMID 41486111mais citado
  4. Ad astra per aspera: treatment challenges and opportunities for children with spinal muscular atrophy and tracheostomy.
    Gene therapy· 2026· PMID 41291051mais citado
  5. Clinical-genetic features of the TBCE-related spectrum disorders: A focus on the childhood-onset neurodegenerative phenotype.
    Molecular genetics and metabolism· 2026· PMID 41833177mais citado
  6. VRK1 variants at the cross road of Cajal body neuropathogenic mechanisms in distal neuropathies and motor neuron diseases.
    Neurobiol Dis· 2023· PMID 37257665recente
  7. Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen.
    J Neuromuscul Dis· 2023· PMID 37248913recente
  8. Axial postural abnormalities and pain in Parkinson's disease.
    J Neural Transm (Vienna)· 2023· PMID 36550202recente
  9. Prevalence of axial postural abnormalities and their subtypes in Parkinson's disease: a systematic review and meta-analysis.
    J Neurol· 2023· PMID 36098837recente
  10. Association between the Horizontal Gaze Ability and Physical Characteristics of Patients with Dropped Head Syndrome.
    Medicina (Kaunas)· 2022· PMID 35454304recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:73245(Orphanet)
  2. MONDO:0019132(MONDO)
  3. Atrofia Muscular Espinhal — AME(PCDT · Ministério da Saúde)
  4. GARD:18922(GARD (NIH))
  5. Busca completa no PubMed(PubMed)
  6. Q55788501(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata
Compêndio · Raras BR

Síndrome de atrofia muscular espinhal-complexo de Dandy-Walker-catarata

ORPHA:73245 · MONDO:0019132
🇧🇷 Brasil SUS
Triagem
qPCR para deleção de SMN1 em sangue seco
PNTN
Fase 5
Incidência BR
1:10.000
CEAF
1ANusinersenaRisdiplamOnasemnogene abeparvovec
Geral
Prevalência
<1 / 1 000 000
Casos
2 casos conhecidos
Herança
Unknown
CID-10
G12.8 · Outras atrofias musculares espinais e síndromes musculares correlatas
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C4509964
Repurposing
2 candidatos
luteinantioxidant
pirenoxineAGE inhibitor
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades